On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...